Document Detail


The dynamic role of cardiac fibroblasts in development and disease.
MedLine Citation:
PMID:  22878976     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiac fibroblasts are the most abundant cell in the mammalian heart. While they have been historically overlooked in terms of functional contributions to development and physiology, cardiac fibroblasts are now front and center. They are currently recognized as key protagonists during both normal development and cardiomyopathy disease, and work together with cardiomyocytes through paracrine, structural, and potentially electrical interactions. However, the lack of specific biomarkers and fibroblast heterogeneous nature currently convolutes the study of this dynamic cell lineage; though, efforts to advance marker analysis and lineage mapping technologies are ongoing. These tools will help elucidate the functional significance of fibroblast-cardiomyocyte interactions in vivo and delineate the dynamic nature of normal and pathological cardiac fibroblasts. Since therapeutic promise lies in understanding the interface between developmental biology and the postnatal injury response, future studies to understand the divergent roles played by cardiac fibroblasts both in utero and following cardiac insult are essential.
Authors:
Jacquelyn D Lajiness; Simon J Conway
Related Documents :
833016 - A comparison between the one-step and the two-step copper thiocholine procedure for the...
3891396 - Ultrastructural morphometric examinations on the protection provided by prostacyclin ag...
25459636 - Levosimendan: the current situation and new prospects.
25367056 - Heart transplant and 2-year follow up in a child with generalized arterial calcificatio...
833016 - A comparison between the one-step and the two-step copper thiocholine procedure for the...
22000626 - Meta-analysis of randomized controlled trials of intracoronary versus intravenous admin...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2012-08-10
Journal Detail:
Title:  Journal of cardiovascular translational research     Volume:  5     ISSN:  1937-5395     ISO Abbreviation:  J Cardiovasc Transl Res     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-11     Completed Date:  2013-05-21     Revised Date:  2014-09-19    
Medline Journal Info:
Nlm Unique ID:  101468585     Medline TA:  J Cardiovasc Transl Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  739-48     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Biological Markers / metabolism
Cell Communication*
Cell Proliferation
Fibroblasts / metabolism*,  pathology
Gene Expression Regulation, Developmental
Heart Diseases / genetics,  metabolism*,  pathology
Humans
Morphogenesis
Myocardium / metabolism*,  pathology
Regeneration
Signal Transduction
Grant Support
ID/Acronym/Agency:
F30 HL116106/HL/NHLBI NIH HHS; HL60714/HL/NHLBI NIH HHS; R01 HL060714/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Streptozotocin-induced insulin deficiency leads to development of behavioral deficits in rats.
Next Document:  Population genetics of chronic kidney disease: the evolving story of APOL1.